CUAMC
XENE icon

China Universal Asset Management Company’s Xenon Pharmaceuticals XENE Stock Holding History

China Universal Asset Management Company’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$929K Buy
15,384
+621
+4% +$34.5K 0.06% 213
2026
Q1 		$858K Buy
14,763
+2,171
+17% +$100K 0.07% 210
2025
Q4 		$564K Sell
12,592
-923
-7% -$38.8K 0.04% 249
2025
Q3 		$543K Sell
13,515
-1,897
-12% -$66.8K 0.04% 238
2025
Q2 		$482K Buy
15,412
+59
+0.4% +$1.93K 0.05% 243
2025
Q1 		$515K Sell
15,353
-813
-5% -$30.9K 0.05% 246
2024
Q4 		$634K Buy
16,166
+1,594
+11% +$65.9K 0.06% 217
2024
Q3 		$574K Buy
14,572
+5,704
+64% +$230K 0.06% 202
2024
Q2 		$346K Sell
8,868
-5,652
-39% -$226K 0.05% 177
2024
Q1 		$625K Buy
14,520
+5,974
+70% +$275K 0.08% 167
2023
Q4 		$394K Buy
8,546
+6,895
+418% +$244K 0.08% 158
2023
Q3 		$56.4K Buy
1,651
+818
+98% +$30.6K 0.02% 227
2023
Q2 		$32.1K Sell
833
-15
-2% -$596 0.01% 234
2023
Q1 		$30.4K Buy
848
+213
+34% +$7.87K 0.01% 184
2022
Q4 		$25K Buy
635
+52
+9% +$1.89K 0.01% 164
2022
Q3 		$21K Buy
+583
New +$21K 0.01% 155

Other funds holding XENE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

China Universal Asset Management Company's XENE Position: Q2 2026 in Review

China Universal Asset Management Company increased its Xenon Pharmaceuticals (XENE) stake by 4.2% in Q2 2026, buying an estimated $34.5K and bringing the position to 15,384 shares worth $929K. The position accounts for 0.06% of the portfolio, ranked #213.

China Universal Asset Management Company first reported a position in XENE in Q3 2022 and has held it in 16 quarters since. 192 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • China Universal Asset Management Company held 15,384 shares of Xenon Pharmaceuticals worth $929K as of Q2 2026.
  • China Universal Asset Management Company bought 621 Xenon Pharmaceuticals shares in Q2 2026, an estimated $34.5K.
  • Xenon Pharmaceuticals made up 0.06% of China Universal Asset Management Company's portfolio in Q2 2026, its #213 holding.
  • China Universal Asset Management Company first reported a position in Xenon Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 192 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.